Repeat Expansions of RFC1 in Refractory Chronic Cough
- 16 November 2022
- journal article
- letter
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 163 (4), 911-915
- https://doi.org/10.1016/j.chest.2022.11.014
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trialsThe Lancet, 2022
- Motor neuron pathology in CANVAS due to RFC1 expansionsBrain, 2021
- Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 DiseaseNeurology, 2021
- Prevalence of RFC1 -mediated spinocerebellar ataxia in a North American ataxia cohortNeurology Genetics, 2020
- ERS guidelines on the diagnosis and treatment of chronic cough in adults and childrenEuropean Respiratory Journal, 2019
- Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxiaNature Genetics, 2019
- Classification of Cough as a Symptom in Adults and Management AlgorithmsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2017
- Arnold’s nerve cough reflex: evidence for chronic cough as a sensory vagal neuropathy2014
- Expert opinion on the cough hypersensitivity syndrome in respiratory medicineEuropean Respiratory Journal, 2014
- Quality of life in patients with chronic coughTherapeutic Advances in Respiratory Disease, 2010